These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 18670246)
21. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition. Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148 [TBL] [Abstract][Full Text] [Related]
22. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity. Kotwal R; Guerdjikova A; McElroy SL; Keck PE Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522 [TBL] [Abstract][Full Text] [Related]
23. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Zhong N; Wu XP; Xu ZR; Wang AH; Luo XH; Cao XZ; Xie H; Shan PF; Liao EY Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886 [TBL] [Abstract][Full Text] [Related]
25. [Serum leptin and insulin resistance in obesity and effects of sibutramine on them]. Wu J; Lei MX; Chen HL Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):605-7. PubMed ID: 15804071 [TBL] [Abstract][Full Text] [Related]
26. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR; Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690 [TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients. Rosenstock J; Hollander P; Gadde KM; Sun X; Strauss R; Leung A; Diabetes Care; 2007 Jun; 30(6):1480-6. PubMed ID: 17363756 [TBL] [Abstract][Full Text] [Related]
28. Continuing weight-loss effect after topiramate discontinuation in obese persons with schizophrenia: a pilot open-label study. Liang CS; Yang FW; Huang SY; Ho PS Pharmacopsychiatry; 2014 Jul; 47(4-5):162-8. PubMed ID: 24936804 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Preuss HG; Garis RI; Bramble JD; Bagchi D; Bagchi M; Rao CV; Satyanarayana S Int J Clin Pharmacol Res; 2005; 25(3):133-44. PubMed ID: 16366421 [TBL] [Abstract][Full Text] [Related]
30. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849 [TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. Guille C; Sachs G Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1035-9. PubMed ID: 12452523 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age. Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232 [TBL] [Abstract][Full Text] [Related]
33. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565 [TBL] [Abstract][Full Text] [Related]
34. The effect of carbamazepine treatment on serum leptin levels. Uludag IF; Kulu U; Sener U; Kose S; Zorlu Y Epilepsy Res; 2009 Sep; 86(1):48-53. PubMed ID: 19473818 [TBL] [Abstract][Full Text] [Related]
35. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Völkl TM; Simm D; Beier C; Dörr HG Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852 [TBL] [Abstract][Full Text] [Related]
36. Serum leptin monitoring in anorectic patients during refeeding therapy. Lob S; Pickel J; Bidlingmaier M; Schaaf L; Backmund H; Gerlinghoff M; Stalla GK Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):278-82. PubMed ID: 12951634 [TBL] [Abstract][Full Text] [Related]
37. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss. Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419 [TBL] [Abstract][Full Text] [Related]
38. Topiramate induces weight loss and improves insulin sensitivity in dietary obese rats: comparison to sibutramine. Abo-Elmatty DM; Zaitone SA Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1187-95. PubMed ID: 22165681 [TBL] [Abstract][Full Text] [Related]
39. Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Lévy E; Agbokou C; Ferreri F; Chouinard G; Margolese HC Can J Clin Pharmacol; 2007; 14(2):e234-9. PubMed ID: 17565171 [TBL] [Abstract][Full Text] [Related]
40. Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid. Greco R; Latini G; Chiarelli F; Iannetti P; Verrotti A Neurology; 2005 Dec; 65(11):1808-9. PubMed ID: 16344528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]